OXYNORM

This brand name is authorized in Australia, Austria, Brazil, Cyprus, Finland, France, Hong Kong SAR China, Ireland, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug OXYNORM contains one active pharmaceutical ingredient (API):

1
UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE
 

Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative.

 
Read more about Oxycodone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 OXYNORM 10 mg/ml Solution for injection or infusion MPI, EU: SmPC Υπουργείο Υγείας (CY)
 OXYNORM Concentrate oral solution MPI, EU: SmPC Υπουργείο Υγείας (CY)
 OXYNORM Capsule, hard MPI, EU: SmPC Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N02AA05 Oxycodone N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 12031F, 12074L, 12311Y, 12314D, 5190E, 5191F, 5197M, 8464L, 8501K, 8502L, 8644Y
BR Câmara de Regulação do Mercado de Medicamentos 556721030004905, 556721030005005
ES Centro de información online de medicamentos de la AEMPS 66574, 66575, 66576, 66614, 71243
FI Lääkealan turvallisuus- ja kehittämiskeskus 003449, 003485, 004795, 005068, 005088, 006244, 006255, 006263, 022119
FR Base de données publique des médicaments 60209645, 60629186, 61007415, 61115864, 61613434, 65821685, 66268312, 67565715, 68127381
GB Medicines & Healthcare Products Regulatory Agency 155455, 162207, 162209, 162211, 186052, 186054, 28958, 28961, 28964, 28976, 28984, 376967, 376969, 376971, 381590, 46355, 46361
HK Department of Health Drug Office 59575, 59576, 59577, 61835, 66357, 66358
IE Health Products Regulatory Authority 38149, 38162, 38174, 38196, 38239, 38546, 38710, 59007, 59017, 59024, 59073
NL Z-Index G-Standaard 14903547, 14930978
NL Z-Index G-Standaard, PRK 68209, 68217, 68225, 70726, 72761, 94374, 94390, 94412
NZ Medicines and Medical Devices Safety Authority 11876, 12258, 13456, 9550, 9551, 9552
PL Rejestru Produktów Leczniczych 100206840
SG Health Sciences Authority 13079P, 13081P, 13083P, 13733P, 14125P, 14126P
TN Direction de la Pharmacie et du Médicament 16263021, 16263022, 16263023
ZA Health Products Regulatory Authority 41/2.9/1103, 41/2.9/1104, 41/2.9/1105, 46/2.9/0718, 46/2.9/0719

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.